A study presented at the 2018 ONS Annual Congress explored whether aromatherapy and reflexology can ease anxiety and pain for patients undergoing brachytherapy for cervical cancer.
ASCO and Cancer Care Ontario issued a joint update to guidelines for brachytherapy for prostate cancer that take into account new evidence.
An investigation on the late side effects of a combination of two forms of brachytherapy to treat cervical cancer has revealed that the technique delivers higher radiation doses to the tumor without additional treatment-related complications afterwards.
Brachytherapy, with or without external beam radiation, can improve survival in women with inoperable, early stage endometrial cancer.
High-dose-rate (HDR) brachytherapy is typically used as a dose-escalating boost for external beam radiotherapy for prostate cancer; however, some researchers believe it might be close to graduating to a viable monotherapy.
Specific guidance for delivering high dose-rate brachytherapy to improve quality and safety is offered in a new white paper from the American Society for Radiation Oncology (ASTRO).
Long-term outcomes of breast cancer patients receiving adjuvant accelerated partial breast irradiation after breast-conserving surgery show excellent tumor control with minimal late toxicity.
When comparing treatments designed to enable long-term breast preservation for older women with invasive breast cancer, researchers found that those treated with brachytherapy were at higher risk for a later mastectomy.
Brachytherapy treatment was found to be associated with better cause-specific survival and overall survival in women with cervical cancer in a new study.
or women with stage IIIB squamous cervical cancer, cisplatin added to radiotherapy plus high-dose-rate brachytherapy (HDRB) is associated with improved disease-free survival.
Accelerated partial breast irradiation is an option for brachytherapy that can deliver higher doses with better cosmesis for select patients with breast cancer.
A posttreatment assessment of men who underwent treatment for prostate cancer revealed a side effect that has a significant impact on patients.
The breast cancer treatment brachytherapy, heralded for its low complication rates, actually results in more complications than whole-breast radiation 1 year after treatment.
Researchers have identified 12 genetic markers linked with susceptibility for erectile dysfunction after radiotherapy for prostate cancer.
Although brachytherapy has not been considered very effective for high-risk prostate cancer, it reduced disease-specific mortality compared with external beam radiation alone.
Two studies published in International Journal of Radiation Oncology*Biology*Physics indicate that proton therapy is a useful treatment for prostate cancer.
Many women who underwent accelerated partial breast irradiation using brachytherapy were deemed cautionary or unsuitable for the procedure based on guidelines later issued by ASTRO.
Although popular among older women with breast cancer, accelerated partial breast brachytherapy may be less effective and more toxic than standard whole breast irradiation in these patients.
Data presented on the evolving role of radiation therapy in local and regional tumor control at the ASCO 2010 Breast Cancer Symposium, October 1-3, 2010, are reviewed.
Prostate cancer patients who receive the optimum radiation dose on the same day as their brachytherapy implant may have a lower risk of relapse, according to a study conducted by researchers at the University Hospital of Navarre.
Modern radiotherapy achieves cure rates comparable to surgery for early stage prostate cancer and with androgen deprivation therapy, is the optimal treatment for transcasular extension of disease
Sign Up for Free e-newsletters
- Study Finds Association Between Folate Intake and Risk of Cutaneous Melanoma
- Melanoma Outcomes Improved With Nivolumab Alone or Plus Ipilimumab
- Encorafenib, Binimetinib Combination Receives FDA Approval for Mutation-Positive Melanoma
- Certain Risk Factors May Decrease Overall Survival in Pediatric B-NHL
- Oral Contraceptive Use May Not Be Associated With Increased Melanoma Risk
- Implementing an Ambulatory Adherence Program May Improve Oral Anticancer Medications Compliance
- Exercise Habits Influence Mortality in Adult Survivors of Childhood Cancer
- Managing Dyspnea With Fentanyl in Patients With Cancer at End of Life
- CALM: A Depression Intervention for Cancer Patients at the End of Life
- High BMI Among Premenopausal Women May Improve Risk for Breast Cancer
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|